Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage
- PMID: 20107235
- PMCID: PMC3131787
- DOI: 10.4037/ajcc2010156
Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage
Abstract
Background: Patients with aneurysmal subarachnoid hemorrhage experience myocardial injury at the time of rupture, but its effect on functional recovery and disability is unclear.
Objective: To describe the prevalence of myocardial injury, as indicated by high serum levels of cardiac troponin I (≥0.3 ng/mL), within the first 5 days after aneurysmal subarachnoid hemorrhage and the effect of the injury on 3-month functional recovery and disability.
Methods: In a prospective longitudinal study, 239 patients with Hunt/Hess grade 3 or greater and/or Fisher grade 2 or greater at admission had serum level of troponin I measured on days 0 to 5. Patients were interviewed at 3 months to evaluate functional recovery (Glasgow Outcome Scale) and functional disability (Modified Rankin Scale). Statistics included χ² analysis, t tests, and binary logistic regression.
Results: Troponin values were elevated in 33.5% of the patients, and few patients in either group had a history of coronary artery disease (7.4% with troponin levels ≥0.3 ng/mL vs 2.7% with levels <0.3 ng/mL, P = .12). Higher troponin levels were significantly related to age and Hunt/Hess and Fisher grades, but not race, and were significantly associated with poorer functional recovery (P < .001) and more functional disability (P < .001). Even after controls for age, race, and more severe Hunt/Hess grades, higher levels remained a significant predictor of poorer functional recovery (P = .04) and disability (P = .01). CONCLUSION Elevated levels of cardiac troponin I after aneurysmal subarachnoid hemorrhage are common in patients with no cardiac history, are associated with severity of the hemorrhage, and are independently predictive of poorer functional recovery and increased disability.
Comment in
-
Evidence-based review and discussion points.Am J Crit Care. 2010 Nov;19(6):530-1. doi: 10.4037/ajcc2010256. Am J Crit Care. 2010. PMID: 21064231 No abstract available.
Similar articles
-
Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage.Stroke. 2009 Nov;40(11):3478-84. doi: 10.1161/STROKEAHA.109.556753. Epub 2009 Aug 27. Stroke. 2009. PMID: 19713541 Free PMC article.
-
The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage.Acta Neurochir (Wien). 1998;140(1):87-93. doi: 10.1007/s007010050063. Acta Neurochir (Wien). 1998. PMID: 9522914
-
Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.J Neurosurg. 2019 Feb 1;132(2):400-407. doi: 10.3171/2018.9.JNS181975. Print 2020 Feb 1. J Neurosurg. 2019. PMID: 30717052
-
Predictors of neurocardiogenic injury after subarachnoid hemorrhage.Stroke. 2004 Feb;35(2):548-51. doi: 10.1161/01.STR.0000114874.96688.54. Epub 2004 Jan 22. Stroke. 2004. PMID: 14739408 Clinical Trial.
-
Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage.Crit Care Med. 2012 Jan;40(1):223-32. doi: 10.1097/CCM.0b013e31822e9fab. Crit Care Med. 2012. PMID: 21926590
Cited by
-
Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: is there a proven role?Neurocrit Care. 2013 Apr;18(2):271-84. doi: 10.1007/s12028-012-9804-z. Neurocrit Care. 2013. PMID: 23238984 Review.
-
Cardiac Troponin Elevation and Outcome in Subarachnoid Hemorrhage.Cureus. 2020 Aug 16;12(8):e9792. doi: 10.7759/cureus.9792. Cureus. 2020. PMID: 32821636 Free PMC article. Review.
-
Troponin elevation in conditions other than acute coronary syndromes.Vasc Health Risk Manag. 2011;7:597-603. doi: 10.2147/VHRM.S24509. Epub 2011 Sep 22. Vasc Health Risk Manag. 2011. PMID: 22102783 Free PMC article. Review.
-
Brain-Heart Axis and the Inflammatory Response: Connecting Stroke and Cardiac Dysfunction.Cardiology. 2024;149(4):369-382. doi: 10.1159/000538409. Epub 2024 Apr 4. Cardiology. 2024. PMID: 38574466 Free PMC article. Review.
-
Cardiac abnormalities after aneurysmal subarachnoid hemorrhage: effects of β-blockers and angiotensin-converting enzyme inhibitors.Am J Crit Care. 2014 Jan;23(1):30-9. doi: 10.4037/ajcc2014326. Am J Crit Care. 2014. PMID: 24382615 Free PMC article.
References
-
- Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387–396. - PubMed
-
- Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36(4):1328–1335. - PubMed
-
- Naidech AN, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851–2856. - PubMed
-
- Smith M. Intensive care management of patients with subarachnoid haemorrhage. Curr Opin Anesthesiol. 2007;20:400–407. - PubMed
-
- Banki N, Kopelnik A, Dae M, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314–3319. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials